New Alzheimer’s Drug May Help Slow the Rate of Cognitive Decline

(UNDATED) — A spokesman for the Iowa chapter of the Alzheimer’s Association says an experimental drug being tested on people with the disease is showing promise and is very encouraging. Tim Harrington says the drug is called Lecanemab and medical reports out this week say it can slow the rate of cognitive decline by 27 percent, which he calls significant. The clinical trial is in its third phase, so the next step is getting the F-D-A to approve the drug as a viable treatment, perhaps early next year. More than six-million people nationwide are living with Alzheimer’s disease, including 66-thousand in Iowa.